Hederagenin, a compound from Hedera helix, has anti-cancer, anti-inflammatory, anti-depressant, and anti-fibrosis properties. This study shows that hederagenin suppresses ovarian cancer cell growth, induces apoptosis, alters mitochondrial morphology, and modulates the protein Drp1 to inhibit cancer progression.
Researchers developed a method to extract allicin from garlic and found it remains stable at low temperatures. In zebrafish studies, allicin showed antioxidant, anti-proliferative, apoptotic, and anti-angiogenic properties. This suggests allicin could be investigated as a potential anti-cancer agent.
This study investigated the effects of olive oil extract on colorectal cancer cells and bone marrow-derived stem cells. Results showed reduced cell migration and colony formation, suggesting potential therapeutic benefits against colorectal cancer.
Scientists studied the 5th day germinated sprouts of seeds for their potential as an anticancer therapy. The sprouts were found to inhibit HDAC activity and have antioxidant properties, making them a promising alternative for preventing liver diseases. Thymoquinone, a compound found in the sprouts, showed strong interaction with HDAC protein.
A study on Averrhoa carambola fruit found it rich in nutrients and vitamins, with higher antioxidant activity and potential health benefits. It could be a valuable source of nutraceutical compounds.
Maackiain (Mac), a compound from Sophora flavescens, shows potential for treating cervical cancer due to its neuroprotective, anti-allergic, anti-inflammatory, and pro-apoptotic properties. Further research is needed to confirm its therapeutic benefits.